Skip to main content

Table 2 Laterality, initial and final VA, ocular manifestations, OCT findings, follow-up duration and treatment

From: The clinical spectrum of ocular bartonellosis: a retrospective study at a tertiary centre in Malaysia

Patient No.

Lat

Eye

Initial VA

Final VA

Ocular manifestations

OCT findings

Follow up

Treatment

1

BE

OS

OD

6/7.5

6/20

6/6

6/6

LE neuroretinits & flame haemorrhage (at optic disc margin), BE small retinal white lesions

LE SRF under macula & hyperreflective foci within OPL (HE)

23 wks

Doxycycline × 6wks

2

BE

OS

OD

6/60

6/6

6/60

6/7.5

RE neuroretinitis, LE flame haemorrhage (at optic disc margin), BE small retinal white lesions

RE SRF under macula & hyperreflective foci within OPL (HE)

16 wks

Ciprofloxacin × 5 wks

Oral Prednisolone × 1mo

3

BE

OS

OD

6/15

6/6

RE neuroretinitis & flame haemorrhage (at optic disc margin), LE one small flame haemorrhage at supratemporal arcade, BE small retina white lesions

RE hyperreflective foci within OPL (HE), IRF (CMO) & SRF under macula

Doxycycline × 6 wks

4

BE

OS

OD

CF

6/9

6/9

6/6

RE neuroretinitis, small flame haemorrhage (at optic disc margin) with marked retinal vessels tortuosity & dilatation, BE small retinal white lesions

RE SRF under macula & hyperreflective foci within OPL (HE)

9 wks

Doxycycline × 9 days Azithromycin ×4 wks

Oral Prednisolone ×  1 mo

5

BE

OS

OD

6/6

6/12

6/6

6/6

LE neuroretinitis, BE small retinal white lesions

RE hyperreflective RNFL foci (retinitis), hyperreflective foci within OPL (HE) & IRF

7 wks

Ciprofloxacin ×3 days

Augmentin × 2wks

6

BE

OS

OD

6/30

HM

-

-

BE neuroretinitis and flame haemorrhages (at BE optic disc margin), BE small retina white lesions with marked retinal vessels tortuosity & dilatation (L > R)

BE SRF under macula (L > R) & hyperreflective foci within OPL (HE)

Doxycycline × 2 wks

7

BE

OS

OD

1/60

6/9

6/18

6/9

RE neuroretinitis, flame haemorrhage (at optic disc margin) with marked retinal vessels tortuosity & dilatation, BE small retinal white lesions

RE IRF (CMO), SRF under macula & hyperreflective foci within OPL (HE)

6 wks

Doxycycline × 6 wks

8

BE

OS

OD

6/9

6/9

6/9

6/9

BE Large granulomatous lesions at palpebral conjunctivae

16 wks

Erythromycin × 2 wks

9

BE

OS

OD

6/9

6/9

6/9

6/9

BE neuroretinitis (partial macular star) & BE small retinal white lesions

BE hyperreflective foci within OPL (HE)

36 wks

10

LE

OS

OD

6/9

6/9

LE granulomatous follicular conjunctivitis

Doxycycline × 1 wk

11

RE

OS

OD

6/6

6/6

6/6

6/6

RE granulomatous follicular conjunctivitis

2 wks

Doxycycline × 1 wk

12

LE

OS

OD

6/6

6/9

6/6

6/9

LE optic disc swelling with vitritis & LE small retinal white lesions

LE PVD with hyperreflective spots in vitreous (vitritis) & swollen LE ONH

5 wks

Ciprofloxacin × 1 mo

13

BE

OS

OD

6/6

6/38

6/6

6/6

LE neuroretinitis, BE small retinal white lesions

LE SRF under macula & BE hyperreflective foci within OPL (HE)

8 wks

Doxycycline × 6 wks

  1. Lat Laterality, BE Both eyes, RE Right eye, LE Left eye, OS Right eye, OD Left eye, CF Counting finger, HM Hand movement, OCT Optical coherence tomography, SRF Subretinal fluid, OPL Outer plexiform layer, HE Hard exudate, CMO Cystoid macular oedema, IRF Intraretinal fluid, PVD {posterior vitreous detachment, ONH Optic nerve head